From DCAT Value Chain Insights (VCI)
Symbiosis Pharmaceutical Services, a contract manufacturing organization (CMO) of sterile injectables, has appointed Joanne Anderson as its new business development director and a member of management team.
The company has promoted Mrs Anderson to the role following her three successful years with the Scotland-based pharmaceutical CMO.
Reporting to the chief executive officer, her responsibilities will include the strategic and operational management of all sales and marketing activities for Symbiosis globally.
A qualified analytical chemist with an MBA, Mrs Anderson has worked in the biopharmaceutical outsourcing sector for almost 15 years and has spent the last eight years specializing in the field of sterile injectable products for clinical trials and low volume commercial supply.
Source: Symbiosis Pharmaceutical Services
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription